Gain Therapeutics Inc Sustainability Reports
Gain Therapeutics, Inc. is a clinical-stage biotechnology company that utilizes its proprietary computational drug discovery platform, Magellan, to discover and develop novel small molecule allosteric therapies. The company primarily focuses on treating neurodegenerative diseases, lysosomal storage disorders, and other protein misfolding conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00W7D7CK7
3 reports from 2023 to 2025
